Charles River Laboratories
Yahoo Finance • last month
Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Charles River Laboratories International's (NYSE:CRL) stock is up by 1.0% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to stu... Full story
Yahoo Finance • 2 months ago
Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL)
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The Mid Company Fund (Institutional... Full story
Yahoo Finance • 7 months ago
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Powered by digital pathology and AI algorithms, PatholytixForesight drives speed and quality in toxicologic pathology practices WILMINGTON, Mass. & DUBLIN, April 11, 2024--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (N... Full story
Yahoo Finance • 7 months ago
Charles River Laboratories International, Inc.'s (NYSE:CRL) Stock Is Going Strong: Is the Market Following Fundamentals?
Charles River Laboratories International (NYSE:CRL) has had a great run on the share market with its stock up by a significant 16% over the last three months. Given the company's impressive performance, we decided to study its financial in... Full story
Yahoo Finance • 9 months ago
Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
– Fourth-Quarter Revenue of $1.01 Billion and Full-Year Revenue of $4.13 Billion – – Fourth-Quarter GAAP Earnings per Share of $3.62 and Non-GAAP Earnings per Share of $2.46 – – Full-Year GAAP Earnings per Share of $9.22 and Non-GAAP Ear... Full story
Yahoo Finance • 9 months ago
Charles River Laboratories International's (NYSE:CRL) five-year earnings growth trails the decent shareholder returns
Passive investing in index funds can generate returns that roughly match the overall market. But the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, the Charles River Laboratorie... Full story
Yahoo Finance • 10 months ago
10 Narrow Moat Stocks Hedge Funds Are Buying
In this article, we discuss the 10 narrow moat stocks hedge funds are buying. If you want to read about some more narrow moat stocks, go directly to 5 Narrow Moat Stocks Hedge Funds Are Buying. Investors who are new to the stock market of... Full story
Yahoo Finance • 11 months ago
Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration
Charles River’s Memphis facility approved to manufacture Vertex’s CASGEVY™ therapy, the world’s first gene-edited therapy targeting severe sickle cell disease WILMINGTON, Mass. & MEMPHIS, Tenn., December 18, 2023--(BUSINESS WIRE)--Charles... Full story
Yahoo Finance • 11 months ago
Investigation Alert FedEx, Charles River, Acadia Healthcare, and Hawaiian Electric: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
SAN DIEGO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- FedEx Corporation (NYSE: FDX) Johnson Fistel, LLP is investigating potential claims on behalf of FedEx Corporation (NYSE: FDX) against certain of its officers and directors. If you are a cu... Full story
Yahoo Finance • 11 months ago
Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
Company will perform plasmid DNA production in support of early phase trials for SPG56 Hereditary Spastic Paraplegia WILMINGTON, Mass., November 28, 2023--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Gen... Full story
Yahoo Finance • 11 months ago
Charles River Laboratories to Present at Evercore ISI Investor Conference
WILMINGTON, Mass., November 27, 2023--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29th, at 9:1... Full story
Yahoo Finance • 12 months ago
Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products
New option for cryopreserved leukopaks supports demand of gene-modified cell therapy developmentand manufacturing WILMINGTON, Mass., November 16, 2023--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today anno... Full story
Yahoo Finance • 12 months ago
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
Strategic partnership includes co-development of patient-derived xenograft (PDX) Digital Twins for in vivo oncology research Charles River to make an equity investment in Aitia as part of the agreement WILMINGTON, Mass. and SOMERVILLE, Ma... Full story
Yahoo Finance • 12 months ago
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2023 Earnings Call Transcript
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2023 Earnings Call Transcript November 8, 2023 Charles River Laboratories International, Inc. beats earnings expectations. Reported EPS is $2.72, expectations were $2.35. Opera... Full story
Yahoo Finance • 12 months ago
Charles River Laboratories Announces Third-Quarter 2023 Results
– Third-Quarter Revenue of $1.03 Billion – – Third-Quarter GAAP Earnings per Share of $1.69 and Non-GAAP Earnings per Share of $2.72 – – Updates 2023 Guidance – WILMINGTON, Mass., November 08, 2023--(BUSINESS WIRE)--Charles River Labora... Full story
Yahoo Finance • last year
Long-Term Returns of Billionaire Barry Rosenstein’s Activist Targets
In this article, we discuss the long-term returns of Rosenstein's Jana Partners' activist targets. If you want to see more stocks in this selection, check out Long-Term Returns of Jana Partners'5 Activist Targets. Billionaire Barry Rosens... Full story
Yahoo Finance • last year
Lifshitz Law PLLC Announces Investigations of Luminar Technologies, Inc. (NASDAQ: LAZR), NextEra Energy, Inc. (NYSE: NEE), Cutera, Inc. (NASDAQ: CUTR), and Charles River Laboratories International, Inc. (NYSE: CRL)
NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Luminar Technologies, Inc. (NASDAQ: LAZR) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegation... Full story
Yahoo Finance • last year
Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods
NGS assay demonstrated a broader detection range than standard in vivo tests with comparable or higher analytical sensitivity WILMINGTON, Mass. & PARIS, September 06, 2023--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (... Full story
Yahoo Finance • last year
Unveiling Charles River Laboratories International's Value: Is It Really Priced Right? A ...
Charles River Laboratories International Inc (NYSE:CRL)'s stock has recently experienced a daily gain of 2.84%, and a 3-month gain of 6.87%. With an Earnings Per Share (EPS) of 9.43, the stock appears to be significantly undervalued. This... Full story
Yahoo Finance • last year
Charles River Laboratories International's (NYSE:CRL) five-year total shareholder returns outpace the underlying earnings growth
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And in our experience, buying the right stocks can give your wealth a significant boost. To wit, the Char... Full story
